UPDATE
GSK recalls weight-loss drug Alli following evidence of tampering
GlaxoSmithKline has issued an alert and US voluntary recall of its OTC weight-loss drug Alli after discovering some bottles had been tampered with.
UPDATE
GlaxoSmithKline has issued an alert and US voluntary recall of its OTC weight-loss drug Alli after discovering some bottles had been tampered with.
Demand from biotech firms and Big Pharma’s need to refill its pipeline is driving the preclinical services industry, say analysts at this year’s Society of Toxicology (SOT) meeting.
UPDATE
ADC-makers could avoid using costly cytotoxics in antibody-drug conjugates (ADCs) by using near‐infrared (NIR) light to activate targeted cell-killing payloads, says Goodwin who has team up with Aspyrian Therapeutics.